The U.S. Food and Drug Administration (US FDA) has approved the first generic Lexapro tablets (escitalopram) to treat depression and anxiety disorder in adults.
![US FDA Approves Generic Lexapro for Adult Depression, Anxiety Disorder US FDA Approves Generic Lexapro for Adult Depression, Anxiety Disorder](https://images.medindia.net/health-images/1200_1000/Antimicrobial-Resistance.jpg)
Director of the FDA's Center for Drug Evaluation and Research, Janet Woodcock said, "This medication is widely used by people who must manage their condition over time, so it is important to have affordable treatment options."
Escitalopram is packaged with a black box warning regarding an increased risk of suicidal thoughts and behavior among children, adolescents and young adults aged 18-24 years when first starting treatment. Those over the age of 24-years showed no such risk, and patients 65-years and older showed a decreased risk.
Source-Medindia